Mogamulizumab May Be Effective in Relapsed/Refractory T-Cell Leukemia

Adrienne A. Phillips, MD, MPH, shares results seen with mogamulizumab in the largest randomized clinical trial of relapsed/refractory T-cell leukemia to date.

SHARE